TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Novus Scientific AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
45,589
|
34,825
|
20,591 |
| Financial expenses |
4,654
|
178
|
80 |
| Earnings before taxes |
3,857
|
7,860
|
-5,618 |
| EBITDA |
14,923
|
7,048
|
-6,078 |
| Total assets |
49,136
|
46,190
|
35,836 |
| Current assets |
46,686
|
43,702
|
32,838 |
| Current liabilities |
35,595
|
33,827
|
31,632 |
| Equity capital |
13,541
|
12,363
|
4,204 |
| - share capital |
103
|
101
|
95 |
| Employees (average) |
16
|
16
|
16 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
27.6%
|
26.8%
|
11.7% |
| Turnover per employee |
2,849
|
2,177
|
1,287 |
| Profit as a percentage of turnover |
8.5%
|
22.6%
|
-27.3% |
| Return on assets (ROA) |
17.3%
|
17.4%
|
-15.5% |
| Current ratio |
131.2%
|
129.2%
|
103.8% |
| Return on equity (ROE) |
28.5%
|
63.6%
|
-133.6% |
| Change turnover |
10,136
|
12,773
|
3,653 |
| Change turnover % |
29%
|
58%
|
22% |
| Chg. No. of employees |
0
|
0
|
2 |
| Chg. No. of employees % |
0%
|
0%
|
14% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.